1. Home
  2. ADAG vs GEOS Comparison

ADAG vs GEOS Comparison

Compare ADAG & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • GEOS
  • Stock Information
  • Founded
  • ADAG 2011
  • GEOS 1980
  • Country
  • ADAG China
  • GEOS United States
  • Employees
  • ADAG N/A
  • GEOS N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • GEOS Industrial Machinery/Components
  • Sector
  • ADAG Health Care
  • GEOS Industrials
  • Exchange
  • ADAG Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • ADAG 76.3M
  • GEOS 72.9M
  • IPO Year
  • ADAG 2021
  • GEOS 1997
  • Fundamental
  • Price
  • ADAG $1.90
  • GEOS $11.49
  • Analyst Decision
  • ADAG Strong Buy
  • GEOS
  • Analyst Count
  • ADAG 1
  • GEOS 0
  • Target Price
  • ADAG $8.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • ADAG 75.3K
  • GEOS 93.4K
  • Earning Date
  • ADAG 07-24-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • ADAG N/A
  • GEOS N/A
  • EPS Growth
  • ADAG N/A
  • GEOS N/A
  • EPS
  • ADAG N/A
  • GEOS N/A
  • Revenue
  • ADAG $103,204.00
  • GEOS $116,542,000.00
  • Revenue This Year
  • ADAG $6,488.89
  • GEOS N/A
  • Revenue Next Year
  • ADAG $57.50
  • GEOS N/A
  • P/E Ratio
  • ADAG N/A
  • GEOS N/A
  • Revenue Growth
  • ADAG N/A
  • GEOS N/A
  • 52 Week Low
  • ADAG $1.33
  • GEOS $5.51
  • 52 Week High
  • ADAG $3.58
  • GEOS $13.79
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 52.47
  • GEOS 79.75
  • Support Level
  • ADAG $1.73
  • GEOS $6.52
  • Resistance Level
  • ADAG $2.02
  • GEOS $6.97
  • Average True Range (ATR)
  • ADAG 0.15
  • GEOS 0.69
  • MACD
  • ADAG -0.01
  • GEOS 0.46
  • Stochastic Oscillator
  • ADAG 42.50
  • GEOS 92.30

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: